COMMUNIQUÉS West-GlobeNewswire

SuperSonic Imagine to Introduce Next-Generation Aixplorer® Ultimate Ultrasound Platform at RSNA 2017

21/11/2017 - 19:00

AIX-EN-PROVENCE, France, Nov. 21, 2017 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext:SSI) (FR0010526814), a company specializing in ultrasound medical imaging, announced today that it will showcase the newest version [...]

Invuity Appoints Scott Flora to Board of Directors

21/11/2017 - 18:20

SAN FRANCISCO, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ), a leading medical technology company focused on minimal access surgery, today announced that Scott D. Flora has been appointed to its Board [...]

Abba Medix Grow Facility Improvements and MFT Advances

21/11/2017 - 18:16

TORONTO, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) is pleased to announce that its wholly-owned subsidiary, Abba Medix (“ Abba ”), has been making [...]

Ogilvy CommonHealth Worldwide Co-Publishes Primary Research Exploring In-Office Communication

21/11/2017 - 18:15

PARSIPPANY, N.J., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), the health behavior change specialists of Ogilvy & Mather ( www.ogilvy.com ) and a WPP Health & Wellness [...]

Reporting of transactions made by persons discharging managerial responsibilities in Orphazyme A/S

21/11/2017 - 17:31

Company announcement Orphazyme A/S No. 13/2017 Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 21 November 2017 Pursuant to the Market Abuse Regulation article 19, Orphazyme A/ [...]

Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Front Line Multiple Myeloma

21/11/2017 - 17:12

Company Announcement sBLA submitted to U.S. FDA for daratumumab in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma ineligible for autologous stem [...]

Richardson Healthcare Announces New Preferred Replacement Parts Program and CT Service Training at RSNA 2017

21/11/2017 - 17:00

LAFOX, Ill., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Richardson Healthcare , a Division of Richardson Electronics, Ltd. (NASDAQ: RELL ), will launch its preferred partnership program, branded P3, and Philips CT service [...]

Oshkosh Physician Attends National Physicians Council for Healthcare Policy Meeting in Washington, D.C.

21/11/2017 - 15:55

TUCSON, Ariz., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Albert L. Fisher, M.D., of Oshkosh, Wisconsin, represented the Association of American Physicians and Surgeons (AAPS) at the National Physicians Council for Healthcare [...]

RESULTS FROM THE PHASE III HERCULES STUDY OF CAPLACIZUMAB FOR THE TREATMENT OF ACQUIRED TTP SELECTED FOR PRESENTATION IN THE LATE-BREAKING ABSTRACTS SESSION AT THE 2017 ASH ANNUAL MEETING

21/11/2017 - 15:41

GHENT, Belgium, 21 November 2017 (3.30pm CET) - Ablynx NV [Euronext Brussels and Nasdaq: ABLX] today announced that results from its Phase III HERCULES study of caplacizumab have been selected as one of only six [...]

Data from Phase III ALCYONE Study of Daratumumab Accepted for Oral Presentation at Annual Meeting of the American Society of Hematology

21/11/2017 - 15:34

Media Release Late-breaking abstract accepted for oral presentation Data from Phase III ALCYONE study of daratumumab in combination with bortezomib, melphalan and prednisone in front line multiple myeloma Copenhagen, [...]

Biothera Pharmaceuticals to Present at the 29th Annual Piper Jaffray Healthcare Conference

21/11/2017 - 15:23

EAGAN, Minn., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. today announced that Chief Executive Officer Barry Labinger will present at the 29 th Annual Piper Jaffray Healthcare Conference on [...]

Oxford Immunotec to Present at the 29th Annual Piper Jaffray Healthcare Conference

21/11/2017 - 15:15

OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company focused on developing and commercializing [...]

NSS Labs Selected as a 2017 Red Herring Top 100 Global Winner

21/11/2017 - 15:00

AUSTIN, Texas, Nov. 21, 2017 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, fact-based cybersecurity guidance today announced that it has been selected as a winner of the Red [...]

Zynerba Pharmaceuticals Announces Poster Presentation at the 2017 Annual Meeting of the American Epilepsy Society (AES)

21/11/2017 - 15:00

DEVON, Pa., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals , Inc. (NASDAQ: ZYNE ), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically- [...]

Axim Biotechnologies Announces Phase IIa Trial Results Validating its Proprietary Cannabinoid Delivery Method for Treatment of Irritable Bowel Syndrome (IBS)

21/11/2017 - 15:00

NEW YORK, Nov. 21, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced clinical trial results from its first phase II [...]

Nextech Reports Key Wins, Corporate Expansions

21/11/2017 - 14:50

TAMPA, Fla., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of health care technology solutions for specialty physician practices, is pleased to announce a wide variety of corporate wins and [...]

CV Sciences, Inc. Announces its Silver Sponsorship of SOHO Expo in Orlando, FL - December 1-3, 2017

21/11/2017 - 14:45

LAS VEGAS, Nov. 21, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. Announces its Silver Sponsorship of SOHO Expo in Orlando, FL - December 1-3, 2017 Company enters its 3rd year exhibiting its industry-dominating brand, [...]

AC Immune to Host Key Opinion Leader Meeting on Tau as a Therapeutic and Diagnostic Target in Alzheimer's and other Neurodegenerative Diseases

21/11/2017 - 14:32

Lausanne, Switzerland, November 21, 2017 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced that it will [...]

Marrone Bio Innovations, Inc. to Present at 10th Annual LD Micro Main Event Investor Conference in Los Angeles

21/11/2017 - 14:30

DAVIS, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ: MBII ), a leading provider of bio-based pest management and plant health products for the agriculture, [...]